|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/08 | (2006.01) |
| (11) | Number of the document | 3350218 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16766397.0 |
| Date of filing the European patent application | 2016-09-08 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-28 |
| (46) | Date of publication of the claims translation | 2024-04-10 |
| (86) | Number | PCT/IB2016/055339 |
| Date | 2016-09-08 |
| (87) | Number | WO 2017/046676 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| PCT/CN2015/089764 | 2015-09-16 | WO |
| (72) |
ABEND, Johanna , US
DRAGIC, Zorica , CH
FEIRE, Adam Lloyd , US
KNAPP, Mark , US
KOVACS, Steven , US
TRAGGIAI, Elisabetta , CH
WANG, Lichun , CN
WANG, Yongqiang , CN
WU, Danqing , CN
WU, Qilong , CN
XU, Fangmin , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Poliomavirusą neutralizuojantys antikūnai |
| POLYOMAVIRUS NEUTRALIZING ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 10 | 231.00 EUR |
| 2026-09-08 |